Univ. Lille, CNRS, INRAE, Centrale Lille, UMR 8207 - UMET - Unité Matériaux et Transformations, 59000 Lille, France.
Univ. Lille, CNRS, Univ. Polytechnique Hauts-de-France, UMR 8520 - IEMN - Institut d'Electronique de Microélectronique et de Nanotechnologie, 59000 Lille, France.
J Colloid Interface Sci. 2025 Jan;677(Pt A):314-323. doi: 10.1016/j.jcis.2024.07.218. Epub 2024 Jul 28.
Antimicrobial resistance (AMR) is a pressing global health concern. ESKAPEE pathogens, such as Methicillin-resistant Staphylococcus aureus (MRSA) are notable of concern in healthcare settings due to their resistance to critical antibiotics. To combat AMR, the development of alternatives such as bacterial membrane-active agents is crucial. Fatty acids (FAs) have emerged as a sustainable, antibiotic-free solution with inherent antibacterial activity. However, long chain saturated fatty acids (LCFAs) sodium soaps exhibit poorly antibacterial properties in comparison to short chain FAs, believed to be linked to limited solubility in aqueous media.
We employed choline as a chaotropic organic counter-ion to enhance the solubility of LCFAs and investigated their antibacterial effects against MRSA. The optimal medium conditions for micelle formation for LCFAs was first investigated. Then, we determined the critical micelle concentration (CMC), micellar morphology, and aggregation number through surface tension measurements and small angle neutron scattering experiments. Antimicrobial activity was assessed using minimum bactericidal concentration (MBC) assays and time-kill experiments.
We have identified conditions where LCFAs are effective against MRSA for the first time, providing valuable insights for developing new antibacterial agents to fight AMR. LCFAs need to be used above their Krafft temperatures and CMC to exhibit antibacterial efficacy.
抗菌药物耐药性(AMR)是一个紧迫的全球健康问题。由于对关键抗生素的耐药性,医疗保健环境中耐甲氧西林金黄色葡萄球菌(MRSA)等 ESKAPEE 病原体值得关注。为了对抗 AMR,开发细菌膜活性剂等替代品至关重要。脂肪酸(FAs)作为一种具有内在抗菌活性的可持续、无抗生素解决方案已经出现。然而,与短链 FAs 相比,长链饱和脂肪酸(LCFAs)钠盐的抗菌性能较差,据信这与在水介质中溶解度有限有关。
我们使用胆碱作为离液有机抗衡离子来提高 LCFAs 的溶解度,并研究了它们对 MRSA 的抗菌作用。首先研究了 LCFAs 形成胶束的最佳介质条件。然后,我们通过表面张力测量和小角中子散射实验确定了临界胶束浓度(CMC)、胶束形态和聚集数。通过最小杀菌浓度(MBC)测定和时间杀伤实验评估了抗菌活性。
我们首次确定了 LCFAs 对抗 MRSA 有效的条件,为开发新的抗菌剂对抗 AMR 提供了有价值的见解。LCFAs 需要在其克拉夫特点温度和 CMC 以上使用才能表现出抗菌功效。